Sight Sciences

Intro to OMNI

Deborah Ristvedt, DO; and Mathew Walker, OD

Show Description +

Dr. Deborah Ristvedt and Dr. Mathew Walker share the value of MIGS and intervening in the glaucoma management journey sooner with the OMNI Surgical System, including the option to customize patient care regardless of cataracts.

Posted: 4/18/2022

Keywords:

OMNIconnect

•

Implementing OMNI in Your Practice

Up Next

Name: Intro to OMNI
Uploaded: 2022-04-18T16:07:04+00:00
Description: Dr. Deborah Ristvedt and Dr. Mathew Walker share the value of MIGS and intervening in the glaucoma management journey sooner with the OMNI Surgical System, including the option to customize patient care regardless of cataracts.

Patient Selection

Mathew Walker, OD; and Deborah Ristvedt, DO

OMNI^® Surgical System

Real Talk on Interventional Glaucoma – Featuring OMNI Edge

Deborah Ristvedt, DO; Douglas McGraw, DO; and Arkadiy Yadgarov, MD

The Crucial Choice in Combating Glaucoma With Interventional Treatment

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Zarmeena Vendal, MD; and Reay H. Brown, MD

The OMNI<sup>®</sup> Surgical System: Strengthening the Case for Standalone MIGS

The OMNI^® Surgical System: Strengthening the Case for Standalone MIGS

Cathleen McCabe, MD

Shaping the Future of MIGS With the OMNI<sup>®</sup> Surgical System

Shaping the Future of MIGS With the OMNI^® Surgical System

Nathan Radcliffe, MD

New Clinical Data: Suppression of Diurnal IOP Fluctuation with the OMNI<sup>®</sup> Surgical System

New Clinical Data: Suppression of Diurnal IOP Fluctuation with the OMNI^® Surgical System

Brian Flowers, MD

New Clinical Data: Effective IOP Reduction in Hispanic Patients with the OMNI<sup>®</sup> Surgical System

New Clinical Data: Effective IOP Reduction in Hispanic Patients with the OMNI^® Surgical System

Mark J. Gallardo, MD

The OMNI^® Surgical System

OMNI<sup>®</sup> Surgical System in Standalone Cases

OMNI^® Surgical System in Standalone Cases

Deborah Ristvedt, DO, Neil Patel, MD

OMNI<sup>®</sup> Surgical System: Highlights from My First Cases

OMNI^® Surgical System: Highlights from My First Cases

Lawrence Woodard, MD

Implementing OMNI in Your Practice

Intro to OMNI

Deborah Ristvedt, DO; and Mathew Walker, OD

Patient Selection

Mathew Walker, OD; and Deborah Ristvedt, DO

Patient Education

Deborah Ristvedt, DO; and Mathew Walker, OD

Surgical Consult & Planning

Deborah Ristvedt, DO; and Mathew Walker, OD

Day of Surgery

Deborah Ristvedt, DO

Post-op and Follow up

Deborah Ristvedt, DO; and Mathew Walker, OD

Outcomes and Goals

Deborah Ristvedt, DO; and Mathew Walker, OD

Referral Network

Deborah Ristvedt, DO; and Mathew Walker, OD

Pseudophakic MIGS

Patient Identification and Working With the Referral Network

Considerations for Implementation and Pearls for Success

Engaging Technicians and Staff on Implementing Standalone MIGS

Educating Patients on Their Options for Treatment

About Sight Sciences

Our Journey

Back to All Videos

Intro to OMNI

Deborah Ristvedt, DO; and Mathew Walker, OD

Posted: 4/18/2022

Keywords:

OMNIconnect

•

Implementing OMNI in Your Practice

Resources

The Crucial Choice in Combating Glaucoma With Interventional Treatment

View Resource

MIGS Beyond Cataract Surgery: An Interventional Mindset

View Resource

Nine Reasons Why We Perform MIGS with OMNI

View Resource

MIGS Beyond Cataract Surgery

View Resource

Spotlight on OMNI in Standalone Procedures

View Resource

The Benefits of OMNI in Pseudophakic Patients

View Resource

MIGS Algorithm: Navigating A Myriad of Decisions

View Resource

The Changing MIGS Landscape

View Resource

OMNI Surgical System: My First 10 Patients

View Resource

About Sight Sciences

At Sight Sciences, we are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent. Our mission is clear: to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing

Explore more at sightsciences.com

Follow Sight Sciences

IMPORTANT PRODUCT INFORMATION:

The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Do not use the OMNI® in any situations where the iridocorneal angle is compromised or has been damaged (e.g., from trauma or surgery), since it may not be possible to visualize the angle or to properly pass the microcatheter. Do not use the OMNI® in patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma; traumatic or malignant glaucoma; or narrow inlet canals with plateau iris. Do not use the OMNI® Surgical System in quadrants with previous MIGS implants. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events.

Doctors are paid consultants of Sight Sciences, Inc.

© 2025 Sight Sciences. Sight Sciences, the Sight Sciences logo, and OMNI are registered trademarks of Sight Sciences. 04/2025 OM-1129-US.v4